Novo Nordisk has struggled to adapt to very high demand and a market where celebrities are more influential than doctors.

Individualized letters have gone out to 17 major pharmaceutical companies from President Trump, demanding that they cut their drug prices in the US. If they don't agree to comply by Sept. 29, the ...

US stocks finished mostly lower on Thursday as yet more tariff uncertainty weighed on risk appetite, while investors digested ...

Ligand to invest $35 million in exchange for a tiered royalty on future sales of Orchestra’s AVIM therapy and Virtue SAB and an additional $5 million in an equity private placement ...

President Trump urges top pharmaceutical firms to lower U.S. drug prices under his most-favored-nation drug pricing policy ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

Shares of Psyence Biomedical are surging Thursday morning. The stock is gaining following an announcement from the company ...

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Amgen (AMGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the ...

lululemon has many traits of a quality company. It has a strong brand, healthy cash flow, low debt, and a favorable ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

As August 5 approaches, Amgen (AMGN) gears up to reveal its Q2 2025 earnings after market close, and expectations are high ...